National Academies Should Widen Definition Of Panelist Conflict, Report Says
Executive Summary
Nearly 20% of panelists on National Academies of Science committees had financial ties to industry, a Center for Science in the Public Interest study found
You may also be interested in...
Advisory Panel Conflict Waivers To Stay; FDA Will Provide Clarity On Process
FDA's plan for improving its advisory committee member selection process focuses on increasing the transparency and consistency of the existing process rather than an overhaul of its practices
IoM Drug Safety Review Will Consider Advisory Committee Process, FDA Says
The Institute of Medicine will consider FDA's use of advisory committees as part of its review of the agency's handling of drug safety issues
Part D Discount Liability Coming Into Focus: CMS Releases Drug Cost Data
Newly released Medicare Part D data sheds light on the sales hit that branded pharmaceutical manufacturers will face when the coverage gap discount program gets under way in 2011